4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-003564
EVP, Chief Operating Officer gave up 2,012 shares (to pay taxes)
- EVP, Chief Operating Officer acquired 1,654 shares (other)
- EVP, Chief Operating Officer acquired 5,814 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Szekeres David Leslie EVP, Chief Operating Officer | 2022-10-31 | Other acquisition | +1,654 | $3.27 | $5,413 | 22,348 | D |
| Szekeres David Leslie EVP, Chief Operating Officer | 2023-01-13 | Option exercise | +1,250 | 23,598 | D | ||
| Szekeres David Leslie EVP, Chief Operating Officer | 2023-01-13 | Option exercise | +4,564 | 28,162 | D | ||
| Szekeres David Leslie EVP, Chief Operating Officer | 2023-01-13 | Shares withheld for taxes | −2,012 | $3.17 | $6,378 | 26,150 | D |
| Derivatives | |||||||
| Szekeres David Leslie EVP, Chief Operating Officer | 2023-01-13 | Option exercise · Restricted Stock Units | −1,250 | 8,750 | D | ||
| Szekeres David Leslie EVP, Chief Operating Officer | 2023-01-13 | Option exercise · Restricted Stock Units | −4,564 | 32,500 | D | ||
Loading xslF345X03/doc4.xml…